An ensemble method for identifying robust features for biomarker discovery

Computational Methods of Feature Selection

Volumn , Issue , 2007, Pages 377-392

  Chan, Diana ^a   Bridges, Susan M ^a   Burgess, Shane C ^a  

^a MISSISSIPPI STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85130889021     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (19)

1. G. Alexe, S. Alexe, L. Liotta, E. Petricoin, M. Reiss, and P. Hammer. Ovarian cancer detection by logical analysis of proteomic data. Pro-teomics, 4:766-783, 2004.
2. K. Baggerly, J. Morris, and K. Coombes. Reproducibility of seldi-tof protein patterns in serum: Comparing datasets from different experiments. Bioinformatics, 20:777-785, 2004.
3. K. Baggerly, J. Morris, S. Edmonson, and K. Coombes. Signal in noise: Evaluating reported reproducibility of serum proteomics tests for ovarian cancer. Journal of the National Cancer Institute, 97:307-309, 2005.
4. K. Baggerly, J. Morris, J. Wang, D. Gold, L. Xiao, and K. Coombes. A comprehensive approach to the analysis of matrix-assisted laser desorption/ionization-time of flight proteomics spectra from serum samples. Proteomics, 3:1667-1672, 2003.
5. Clinical proteomics program database detailed explanation of proteome quest for data analysis. Web site, Aug 2005. http://home.ccr.cancer.gov/ncifdaproteomics/ppatterns.asp.
6. T. Conrads, M. Zhou, E. Petricoin, L. Liotta, and T. Veenstra. Cancer diagnosis using proteomic patterns. Expert Reviews in Molecular Diagnostic, 3:411-420, 2003.
7. A. Constans. Rethinking clinical proteomics. Scientist, 19, 2005.
8. J. Li, Z. Zhang, J. Rosenweig, Y. Wang, and D. Chan. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clinical Chemistry, 48:1296-1304, 2002.
9. R. Lilien, H. Farid, and B. Donald. Probabilistic disease classification of expression-dependent proteomic data from mass spectrometry of human serum. Journal ofComputational Biology, 10:925-946, 2003.
10. L. Liotta, M. Lowenthal, T. Conrads, T. Veenstra, D. Fishman, and E. Petricoin. Misinformation generated by lack of communication between producers and consumers of publicly available experimental data. Journal ofthe National Cancer Institute, 97:310-314, 2005.
11. E. Petricoin, A. Ardekani, B. Hitt, P. Levine, V. Fusaro, S. Steinberg, G. Mills, C. Simone, D. Fishman, and E. Kohn. Use of proteomic patterns in serum to identify ovarian cancer. Lancet, 359:572-577, 2002.
12. D. Ransohof. Lessons from controversy: ovarian cancer screening and serum proteomics. Journal of the National Cancer Institute, 97:315-319, 2005.
13. J. Sorace and M. Zhan. A data review and re-assessment of ovarian cancer serum proteomic profiling. BMC Bioinformatics, 4, 2003.
14. Medical terminology and drug database. Web site, December 2005. http://www.stj ude.org/glossary.
15. M. Vannucci, N. Sha, and P. Brown. Nir and mass spectra classification: Bayesian methods for wavelet-based feature selection. Chemometrics and Intelligent Laboratory Systems, 77:139-148, 2005.
16. M. Wagner, D. Naik, and A. Pothen. Protocols for disease classification from mass spectrometry data. Proteomics, 3:1692-1698, 2003.
17. I. H. Witten and F. Eibe. Data Mining: Practical Machine Learning Tools and Techniques (Second Edition). Morgan Kaufmann, San Francisco, CA, 2005.
18. B. Wu, T. Abbott, D. Fishman, W. McMurray, G. Mor, K. Stone, D. Ward, K. Williams, and H. Zhao. Comparison of statistical methods for classification of ovarian cancer using mass spectrometry data. BioInformatics, 19, 2003.
19. H. Zhu, C. Yu, and H. Zhang. Tree-based disease classification using protein data. Proteomics, 3:1673-1677, 2003.